 | • レポートコード：QFJ1-5115 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、がん生検の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（組織生検、リキッドバイオプシー、その他）、用途別市場規模（乳がん、結腸直腸がん、子宮頸がん、肺がん、前立腺がん、皮膚がん、血液がん、腎臓がん、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・がん生検の市場動向 ・企業の競争状況、市場シェア ・がん生検の種類別市場規模と予測2016-2027（組織生検、リキッドバイオプシー、その他） ・がん生検の用途別市場規模と予測2016-2027（乳がん、結腸直腸がん、子宮頸がん、肺がん、前立腺がん、皮膚がん、血液がん、腎臓がん、その他） ・がん生検の北米市場規模2016-2027（アメリカ、カナダ） ・がん生検の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・がん生検のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がん生検の中南米市場規模2016-2027（メキシコ、ブラジル） ・がん生検の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Qiagen N.V.、Illumina, Inc.、ANGLE Plc、Myriad Genetics、Hologic, Inc.、Biocept, Inc.、Thermo Fisher Scientific, Inc.、Danaher、Lucence Diagnostics Pte. Ltd.、GRAIL, Inc.、Guardant Health、Exact Sciences Corporation、Freenome Holdings, Inc.、Oncimmune、Chronix Biomedical, Inc.、Personal Genome Diagnostics Inc.） ・結論 |
For most types of cancer, biopsy is the main way doctors diagnose cancer. A biopsy is a microscopic examination of a small amount of tissue. Other tests may indicate that cancer exists, but only biopsy can make a definite diagnosis.
Market Analysis and Insights: Global Cancer Biopsy Market
The global Cancer Biopsy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Biopsy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Biopsy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Biopsy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Biopsy market.
Global Cancer Biopsy Scope and Market Size
Cancer Biopsy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Biopsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Tissue Biopsies
Liquid Biopsies
Others
Segment by Application
Breast Cancer
Colorectal Cancer
Cervical Cancers
Lung Cancers
Prostate Cancers
Skin Cancers
Blood Cancers
Kidney Cancers
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Qiagen N.V.
Illumina, Inc.
ANGLE Plc
Myriad Genetics
Hologic, Inc.
Biocept, Inc.
Thermo Fisher Scientific, Inc.
Danaher
Lucence Diagnostics Pte. Ltd.
GRAIL, Inc.
Guardant Health
Exact Sciences Corporation
Freenome Holdings, Inc.
Oncimmune
Chronix Biomedical, Inc.
Personal Genome Diagnostics Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Biopsy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tissue Biopsies
1.2.3 Liquid Biopsies
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cancer Biopsy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Breast Cancer
1.3.3 Colorectal Cancer
1.3.4 Cervical Cancers
1.3.5 Lung Cancers
1.3.6 Prostate Cancers
1.3.7 Skin Cancers
1.3.8 Blood Cancers
1.3.9 Kidney Cancers
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Biopsy Market Perspective (2016-2027)
2.2 Cancer Biopsy Growth Trends by Regions
2.2.1 Cancer Biopsy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer Biopsy Historic Market Share by Regions (2016-2021)
2.2.3 Cancer Biopsy Forecasted Market Size by Regions (2022-2027)
2.3 Cancer Biopsy Industry Dynamic
2.3.1 Cancer Biopsy Market Trends
2.3.2 Cancer Biopsy Market Drivers
2.3.3 Cancer Biopsy Market Challenges
2.3.4 Cancer Biopsy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Biopsy Players by Revenue
3.1.1 Global Top Cancer Biopsy Players by Revenue (2016-2021)
3.1.2 Global Cancer Biopsy Revenue Market Share by Players (2016-2021)
3.2 Global Cancer Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Biopsy Revenue
3.4 Global Cancer Biopsy Market Concentration Ratio
3.4.1 Global Cancer Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Biopsy Revenue in 2020
3.5 Cancer Biopsy Key Players Head office and Area Served
3.6 Key Players Cancer Biopsy Product Solution and Service
3.7 Date of Enter into Cancer Biopsy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Biopsy Breakdown Data by Type
4.1 Global Cancer Biopsy Historic Market Size by Type (2016-2021)
4.2 Global Cancer Biopsy Forecasted Market Size by Type (2022-2027)
5 Cancer Biopsy Breakdown Data by Application
5.1 Global Cancer Biopsy Historic Market Size by Application (2016-2021)
5.2 Global Cancer Biopsy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cancer Biopsy Market Size (2016-2027)
6.2 North America Cancer Biopsy Market Size by Type
6.2.1 North America Cancer Biopsy Market Size by Type (2016-2021)
6.2.2 North America Cancer Biopsy Market Size by Type (2022-2027)
6.2.3 North America Cancer Biopsy Market Size by Type (2016-2027)
6.3 North America Cancer Biopsy Market Size by Application
6.3.1 North America Cancer Biopsy Market Size by Application (2016-2021)
6.3.2 North America Cancer Biopsy Market Size by Application (2022-2027)
6.3.3 North America Cancer Biopsy Market Size by Application (2016-2027)
6.4 North America Cancer Biopsy Market Size by Country
6.4.1 North America Cancer Biopsy Market Size by Country (2016-2021)
6.4.2 North America Cancer Biopsy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cancer Biopsy Market Size (2016-2027)
7.2 Europe Cancer Biopsy Market Size by Type
7.2.1 Europe Cancer Biopsy Market Size by Type (2016-2021)
7.2.2 Europe Cancer Biopsy Market Size by Type (2022-2027)
7.2.3 Europe Cancer Biopsy Market Size by Type (2016-2027)
7.3 Europe Cancer Biopsy Market Size by Application
7.3.1 Europe Cancer Biopsy Market Size by Application (2016-2021)
7.3.2 Europe Cancer Biopsy Market Size by Application (2022-2027)
7.3.3 Europe Cancer Biopsy Market Size by Application (2016-2027)
7.4 Europe Cancer Biopsy Market Size by Country
7.4.1 Europe Cancer Biopsy Market Size by Country (2016-2021)
7.4.2 Europe Cancer Biopsy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cancer Biopsy Market Size (2016-2027)
8.2 Asia-Pacific Cancer Biopsy Market Size by Type
8.2.1 Asia-Pacific Cancer Biopsy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer Biopsy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer Biopsy Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer Biopsy Market Size by Application
8.3.1 Asia-Pacific Cancer Biopsy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer Biopsy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer Biopsy Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer Biopsy Market Size by Region
8.4.1 Asia-Pacific Cancer Biopsy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer Biopsy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cancer Biopsy Market Size (2016-2027)
9.2 Latin America Cancer Biopsy Market Size by Type
9.2.1 Latin America Cancer Biopsy Market Size by Type (2016-2021)
9.2.2 Latin America Cancer Biopsy Market Size by Type (2022-2027)
9.2.3 Latin America Cancer Biopsy Market Size by Type (2016-2027)
9.3 Latin America Cancer Biopsy Market Size by Application
9.3.1 Latin America Cancer Biopsy Market Size by Application (2016-2021)
9.3.2 Latin America Cancer Biopsy Market Size by Application (2022-2027)
9.3.3 Latin America Cancer Biopsy Market Size by Application (2016-2027)
9.4 Latin America Cancer Biopsy Market Size by Country
9.4.1 Latin America Cancer Biopsy Market Size by Country (2016-2021)
9.4.2 Latin America Cancer Biopsy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Biopsy Market Size (2016-2027)
10.2 Middle East & Africa Cancer Biopsy Market Size by Type
10.2.1 Middle East & Africa Cancer Biopsy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer Biopsy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer Biopsy Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer Biopsy Market Size by Application
10.3.1 Middle East & Africa Cancer Biopsy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer Biopsy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer Biopsy Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer Biopsy Market Size by Country
10.4.1 Middle East & Africa Cancer Biopsy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer Biopsy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Qiagen N.V.
11.1.1 Qiagen N.V. Company Details
11.1.2 Qiagen N.V. Business Overview
11.1.3 Qiagen N.V. Cancer Biopsy Introduction
11.1.4 Qiagen N.V. Revenue in Cancer Biopsy Business (2016-2021)
11.1.5 Qiagen N.V. Recent Development
11.2 Illumina, Inc.
11.2.1 Illumina, Inc. Company Details
11.2.2 Illumina, Inc. Business Overview
11.2.3 Illumina, Inc. Cancer Biopsy Introduction
11.2.4 Illumina, Inc. Revenue in Cancer Biopsy Business (2016-2021)
11.2.5 Illumina, Inc. Recent Development
11.3 ANGLE Plc
11.3.1 ANGLE Plc Company Details
11.3.2 ANGLE Plc Business Overview
11.3.3 ANGLE Plc Cancer Biopsy Introduction
11.3.4 ANGLE Plc Revenue in Cancer Biopsy Business (2016-2021)
11.3.5 ANGLE Plc Recent Development
11.4 Myriad Genetics
11.4.1 Myriad Genetics Company Details
11.4.2 Myriad Genetics Business Overview
11.4.3 Myriad Genetics Cancer Biopsy Introduction
11.4.4 Myriad Genetics Revenue in Cancer Biopsy Business (2016-2021)
11.4.5 Myriad Genetics Recent Development
11.5 Hologic, Inc.
11.5.1 Hologic, Inc. Company Details
11.5.2 Hologic, Inc. Business Overview
11.5.3 Hologic, Inc. Cancer Biopsy Introduction
11.5.4 Hologic, Inc. Revenue in Cancer Biopsy Business (2016-2021)
11.5.5 Hologic, Inc. Recent Development
11.6 Biocept, Inc.
11.6.1 Biocept, Inc. Company Details
11.6.2 Biocept, Inc. Business Overview
11.6.3 Biocept, Inc. Cancer Biopsy Introduction
11.6.4 Biocept, Inc. Revenue in Cancer Biopsy Business (2016-2021)
11.6.5 Biocept, Inc. Recent Development
11.7 Thermo Fisher Scientific, Inc.
11.7.1 Thermo Fisher Scientific, Inc. Company Details
11.7.2 Thermo Fisher Scientific, Inc. Business Overview
11.7.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Introduction
11.7.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Biopsy Business (2016-2021)
11.7.5 Thermo Fisher Scientific, Inc. Recent Development
11.8 Danaher
11.8.1 Danaher Company Details
11.8.2 Danaher Business Overview
11.8.3 Danaher Cancer Biopsy Introduction
11.8.4 Danaher Revenue in Cancer Biopsy Business (2016-2021)
11.8.5 Danaher Recent Development
11.9 Lucence Diagnostics Pte. Ltd.
11.9.1 Lucence Diagnostics Pte. Ltd. Company Details
11.9.2 Lucence Diagnostics Pte. Ltd. Business Overview
11.9.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Introduction
11.9.4 Lucence Diagnostics Pte. Ltd. Revenue in Cancer Biopsy Business (2016-2021)
11.9.5 Lucence Diagnostics Pte. Ltd. Recent Development
11.10 GRAIL, Inc.
11.10.1 GRAIL, Inc. Company Details
11.10.2 GRAIL, Inc. Business Overview
11.10.3 GRAIL, Inc. Cancer Biopsy Introduction
11.10.4 GRAIL, Inc. Revenue in Cancer Biopsy Business (2016-2021)
11.10.5 GRAIL, Inc. Recent Development
11.11 Guardant Health
11.11.1 Guardant Health Company Details
11.11.2 Guardant Health Business Overview
11.11.3 Guardant Health Cancer Biopsy Introduction
11.11.4 Guardant Health Revenue in Cancer Biopsy Business (2016-2021)
11.11.5 Guardant Health Recent Development
11.12 Exact Sciences Corporation
11.12.1 Exact Sciences Corporation Company Details
11.12.2 Exact Sciences Corporation Business Overview
11.12.3 Exact Sciences Corporation Cancer Biopsy Introduction
11.12.4 Exact Sciences Corporation Revenue in Cancer Biopsy Business (2016-2021)
11.12.5 Exact Sciences Corporation Recent Development
11.13 Freenome Holdings, Inc.
11.13.1 Freenome Holdings, Inc. Company Details
11.13.2 Freenome Holdings, Inc. Business Overview
11.13.3 Freenome Holdings, Inc. Cancer Biopsy Introduction
11.13.4 Freenome Holdings, Inc. Revenue in Cancer Biopsy Business (2016-2021)
11.13.5 Freenome Holdings, Inc. Recent Development
11.14 Oncimmune
11.14.1 Oncimmune Company Details
11.14.2 Oncimmune Business Overview
11.14.3 Oncimmune Cancer Biopsy Introduction
11.14.4 Oncimmune Revenue in Cancer Biopsy Business (2016-2021)
11.14.5 Oncimmune Recent Development
11.15 Chronix Biomedical, Inc.
11.15.1 Chronix Biomedical, Inc. Company Details
11.15.2 Chronix Biomedical, Inc. Business Overview
11.15.3 Chronix Biomedical, Inc. Cancer Biopsy Introduction
11.15.4 Chronix Biomedical, Inc. Revenue in Cancer Biopsy Business (2016-2021)
11.15.5 Chronix Biomedical, Inc. Recent Development
11.16 Personal Genome Diagnostics Inc.
11.16.1 Personal Genome Diagnostics Inc. Company Details
11.16.2 Personal Genome Diagnostics Inc. Business Overview
11.16.3 Personal Genome Diagnostics Inc. Cancer Biopsy Introduction
11.16.4 Personal Genome Diagnostics Inc. Revenue in Cancer Biopsy Business (2016-2021)
11.16.5 Personal Genome Diagnostics Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cancer Biopsy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tissue Biopsies
Table 3. Key Players of Liquid Biopsies
Table 4. Key Players of Others
Table 5. Global Cancer Biopsy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cancer Biopsy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cancer Biopsy Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Cancer Biopsy Market Share by Regions (2016-2021)
Table 9. Global Cancer Biopsy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Cancer Biopsy Market Share by Regions (2022-2027)
Table 11. Cancer Biopsy Market Trends
Table 12. Cancer Biopsy Market Drivers
Table 13. Cancer Biopsy Market Challenges
Table 14. Cancer Biopsy Market Restraints
Table 15. Global Cancer Biopsy Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Cancer Biopsy Market Share by Players (2016-2021)
Table 17. Global Top Cancer Biopsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Biopsy as of 2020)
Table 18. Ranking of Global Top Cancer Biopsy Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Cancer Biopsy Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cancer Biopsy Product Solution and Service
Table 22. Date of Enter into Cancer Biopsy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cancer Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Cancer Biopsy Revenue Market Share by Type (2016-2021)
Table 26. Global Cancer Biopsy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Cancer Biopsy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Cancer Biopsy Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Cancer Biopsy Revenue Market Share by Application (2016-2021)
Table 30. Global Cancer Biopsy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Cancer Biopsy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Cancer Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Cancer Biopsy Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Cancer Biopsy Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Cancer Biopsy Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Cancer Biopsy Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Cancer Biopsy Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Cancer Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Cancer Biopsy Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Cancer Biopsy Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Cancer Biopsy Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Cancer Biopsy Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Cancer Biopsy Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Cancer Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Cancer Biopsy Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cancer Biopsy Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cancer Biopsy Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cancer Biopsy Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Cancer Biopsy Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Cancer Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Cancer Biopsy Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Cancer Biopsy Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Cancer Biopsy Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Cancer Biopsy Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Cancer Biopsy Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Cancer Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Cancer Biopsy Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cancer Biopsy Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cancer Biopsy Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cancer Biopsy Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Cancer Biopsy Market Size by Country (2022-2027) & (US$ Million)
Table 62. Qiagen N.V. Company Details
Table 63. Qiagen N.V. Business Overview
Table 64. Qiagen N.V. Cancer Biopsy Product
Table 65. Qiagen N.V. Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
Table 66. Qiagen N.V. Recent Development
Table 67. Illumina, Inc. Company Details
Table 68. Illumina, Inc. Business Overview
Table 69. Illumina, Inc. Cancer Biopsy Product
Table 70. Illumina, Inc. Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
Table 71. Illumina, Inc. Recent Development
Table 72. ANGLE Plc Company Details
Table 73. ANGLE Plc Business Overview
Table 74. ANGLE Plc Cancer Biopsy Product
Table 75. ANGLE Plc Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
Table 76. ANGLE Plc Recent Development
Table 77. Myriad Genetics Company Details
Table 78. Myriad Genetics Business Overview
Table 79. Myriad Genetics Cancer Biopsy Product
Table 80. Myriad Genetics Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
Table 81. Myriad Genetics Recent Development
Table 82. Hologic, Inc. Company Details
Table 83. Hologic, Inc. Business Overview
Table 84. Hologic, Inc. Cancer Biopsy Product
Table 85. Hologic, Inc. Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
Table 86. Hologic, Inc. Recent Development
Table 87. Biocept, Inc. Company Details
Table 88. Biocept, Inc. Business Overview
Table 89. Biocept, Inc. Cancer Biopsy Product
Table 90. Biocept, Inc. Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
Table 91. Biocept, Inc. Recent Development
Table 92. Thermo Fisher Scientific, Inc. Company Details
Table 93. Thermo Fisher Scientific, Inc. Business Overview
Table 94. Thermo Fisher Scientific, Inc. Cancer Biopsy Product
Table 95. Thermo Fisher Scientific, Inc. Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
Table 96. Thermo Fisher Scientific, Inc. Recent Development
Table 97. Danaher Company Details
Table 98. Danaher Business Overview
Table 99. Danaher Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
Table 100. Danaher Recent Development
Table 101. Lucence Diagnostics Pte. Ltd. Company Details
Table 102. Lucence Diagnostics Pte. Ltd. Business Overview
Table 103. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product
Table 104. Lucence Diagnostics Pte. Ltd. Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
Table 105. Lucence Diagnostics Pte. Ltd. Recent Development
Table 106. GRAIL, Inc. Company Details
Table 107. GRAIL, Inc. Business Overview
Table 108. GRAIL, Inc. Cancer Biopsy Product
Table 109. GRAIL, Inc. Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
Table 110. GRAIL, Inc. Recent Development
Table 111. Guardant Health Company Details
Table 112. Guardant Health Business Overview
Table 113. Guardant Health Cancer Biopsy Product
Table 114. Guardant Health Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
Table 115. Guardant Health Recent Development
Table 116. Exact Sciences Corporation Company Details
Table 117. Exact Sciences Corporation Business Overview
Table 118. Exact Sciences Corporation Cancer Biopsy Product
Table 119. Exact Sciences Corporation Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
Table 120. Exact Sciences Corporation Recent Development
Table 121. Freenome Holdings, Inc. Company Details
Table 122. Freenome Holdings, Inc. Business Overview
Table 123. Freenome Holdings, Inc. Cancer Biopsy Product
Table 124. Freenome Holdings, Inc. Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
Table 125. Freenome Holdings, Inc. Recent Development
Table 126. Oncimmune Company Details
Table 127. Oncimmune Business Overview
Table 128. Oncimmune Cancer Biopsy Product
Table 129. Oncimmune Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
Table 130. Oncimmune Recent Development
Table 131. Chronix Biomedical, Inc. Company Details
Table 132. Chronix Biomedical, Inc. Business Overview
Table 133. Chronix Biomedical, Inc. Cancer Biopsy Product
Table 134. Chronix Biomedical, Inc. Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
Table 135. Chronix Biomedical, Inc. Recent Development
Table 136. Personal Genome Diagnostics Inc. Company Details
Table 137. Personal Genome Diagnostics Inc. Business Overview
Table 138. Personal Genome Diagnostics Inc. Cancer Biopsy Product
Table 139. Personal Genome Diagnostics Inc. Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
Table 140. Personal Genome Diagnostics Inc. Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Biopsy Market Share by Type: 2020 VS 2027
Figure 2. Tissue Biopsies Features
Figure 3. Liquid Biopsies Features
Figure 4. Others Features
Figure 5. Global Cancer Biopsy Market Share by Application: 2020 VS 2027
Figure 6. Breast Cancer Case Studies
Figure 7. Colorectal Cancer Case Studies
Figure 8. Cervical Cancers Case Studies
Figure 9. Lung Cancers Case Studies
Figure 10. Prostate Cancers Case Studies
Figure 11. Skin Cancers Case Studies
Figure 12. Blood Cancers Case Studies
Figure 13. Kidney Cancers Case Studies
Figure 14. Others Case Studies
Figure 15. Cancer Biopsy Report Years Considered
Figure 16. Global Cancer Biopsy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Cancer Biopsy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Cancer Biopsy Market Share by Regions: 2020 VS 2027
Figure 19. Global Cancer Biopsy Market Share by Regions (2022-2027)
Figure 20. Global Cancer Biopsy Market Share by Players in 2020
Figure 21. Global Top Cancer Biopsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Biopsy as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Cancer Biopsy Revenue in 2020
Figure 23. Global Cancer Biopsy Revenue Market Share by Type (2016-2021)
Figure 24. Global Cancer Biopsy Revenue Market Share by Type (2022-2027)
Figure 25. North America Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Cancer Biopsy Market Share by Type (2016-2027)
Figure 27. North America Cancer Biopsy Market Share by Application (2016-2027)
Figure 28. North America Cancer Biopsy Market Share by Country (2016-2027)
Figure 29. United States Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Cancer Biopsy Market Share by Type (2016-2027)
Figure 33. Europe Cancer Biopsy Market Share by Application (2016-2027)
Figure 34. Europe Cancer Biopsy Market Share by Country (2016-2027)
Figure 35. Germany Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Cancer Biopsy Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Cancer Biopsy Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Cancer Biopsy Market Share by Region (2016-2027)
Figure 45. China Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Cancer Biopsy Market Share by Type (2016-2027)
Figure 53. Latin America Cancer Biopsy Market Share by Application (2016-2027)
Figure 54. Latin America Cancer Biopsy Market Share by Country (2016-2027)
Figure 55. Mexico Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Cancer Biopsy Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Cancer Biopsy Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Cancer Biopsy Market Share by Country (2016-2027)
Figure 61. Turkey Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Qiagen N.V. Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
Figure 65. Illumina, Inc. Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
Figure 66. ANGLE Plc Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
Figure 67. Myriad Genetics Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
Figure 68. Hologic, Inc. Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
Figure 69. Biocept, Inc. Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
Figure 70. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
Figure 71. Danaher Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
Figure 72. Lucence Diagnostics Pte. Ltd. Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
Figure 73. GRAIL, Inc. Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
Figure 74. Guardant Health Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
Figure 75. Exact Sciences Corporation Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
Figure 76. Freenome Holdings, Inc. Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
Figure 77. Oncimmune Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
Figure 78. Chronix Biomedical, Inc. Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
Figure 79. Personal Genome Diagnostics Inc. Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
世界の婦人科がん治療薬市場規模・現状・予測（2021年-2027年） Gynecological Cancers Therapeutics refer to differences in incidence, prevalence, and mortality from gynecologic cancers between population groups. The five main types of gynecologic cancer include cervical cancer, ovarian cancer, endometrial cancer, vaginal cancer, and vulvar cancer. The presence o…- 婦人科癌治療薬のグローバル市場：規模・現状・予測2019-2025 Gynecological Cancers Therapeutics refer to differences in incidence, prevalence, and mortality from gynecologic cancers between population groups. The five main types of gynecologic cancer include cervical cancer, ovarian cancer, endometrial cancer, vaginal cancer, and vulvar cancer.The presence of…
- 婦人科癌治療薬のグローバル市場：規模・現状・予測2019-2025 Gynecological Cancers Therapeutics refer to differences in incidence, prevalence, and mortality from gynecologic cancers between population groups. The five main types of gynecologic cancer include cervical cancer, ovarian cancer, endometrial cancer, vaginal cancer, and vulvar cancer.The presence of…
- 世界の泌尿生殖器がん治療市場規模・現状・予測（2021年-2027年） Genitourinary cancers treatment pertains to the drugs used to cure or halt progress of cancers found in the urinary and the reproductive system, which include prostate cancer, kidney cancer, bladder cancer, testicular cancer and cancers of the penis. Genitourinary cancers treatment is a specialised …
- 血液癌のグローバル市場調査 2019年 The global Hematological Cancers market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hematological Cancers volume and value at global level, regional level and company level. From a global perspective, …